Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) is scheduled to release its earnings data before the market opens on Monday, November 11th. Analysts expect Bioceres Crop Solutions to post earnings of $0.02 per share for the quarter. Persons that wish to listen to the company's earnings conference call can do so using this link.
Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last issued its earnings results on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.20 by ($0.23). The company had revenue of $124.30 million during the quarter, compared to analyst estimates of $126.75 million. Bioceres Crop Solutions had a net margin of 0.68% and a return on equity of 0.93%. During the same quarter last year, the company posted ($0.06) EPS. On average, analysts expect Bioceres Crop Solutions to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Bioceres Crop Solutions Stock Up 1.2 %
Bioceres Crop Solutions stock traded up $0.08 during midday trading on Monday, hitting $6.57. The stock had a trading volume of 125,239 shares, compared to its average volume of 82,910. The company has a current ratio of 1.28, a quick ratio of 0.91 and a debt-to-equity ratio of 0.35. The business has a fifty day moving average price of $8.30 and a 200 day moving average price of $10.12. Bioceres Crop Solutions has a 12 month low of $6.48 and a 12 month high of $14.05. The stock has a market cap of $412.92 million, a P/E ratio of 163.79 and a beta of 0.49.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on BIOX shares. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a "strong-buy" rating in a report on Friday, July 19th. Lake Street Capital dropped their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a "buy" rating on the stock in a research note on Wednesday, September 11th. Oppenheimer decreased their target price on Bioceres Crop Solutions from $16.00 to $13.00 and set an "outperform" rating for the company in a research note on Monday, October 21st. Canaccord Genuity Group dropped their price target on Bioceres Crop Solutions from $12.50 to $10.00 and set a "buy" rating on the stock in a research report on Thursday, October 17th. Finally, Roth Mkm reduced their price objective on Bioceres Crop Solutions from $15.00 to $13.00 and set a "buy" rating for the company in a research report on Wednesday, September 11th. Four research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $12.25.
Read Our Latest Analysis on Bioceres Crop Solutions
About Bioceres Crop Solutions
(
Get Free Report)
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Further Reading
Before you consider Bioceres Crop Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.
While Bioceres Crop Solutions currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
